¿Por qué y cómo tener en cuenta al cannabis en nuestros pacientes fumadores?

dc.contributor.author
Olano Espinosa, Eduardo
dc.contributor.author
Lozano Polo, Adelaida
dc.contributor.author
Grifell Guardia, Marc
dc.contributor.author
Pinet Ogué, María Cristina
dc.contributor.author
Isorna Folgar, Manuel
dc.contributor.author
Moreno Arnedillo, José Javier
dc.contributor.author
Proyecto ÉVICT 1
dc.date.issued
2019-03-07T08:16:48Z
dc.date.issued
2019-03-07T08:16:48Z
dc.date.issued
2018
dc.identifier
Olano Espinosa E, Lozano Polo A, Grifell Guàrdia M, Pinet Ogué MC, Isorna Folgar M, Moreno Arnedillo JJ. Et al. ¿Por qué y cómo tener en cuenta al cannabis en nuestros pacientes fumadores?. Aten Primaria. 2020; 52(1): 47-53 DOI: 10.1016/j.aprim.2018.05.014
dc.identifier
0212-6567
dc.identifier
http://hdl.handle.net/10230/36772
dc.identifier
http://dx.doi.org/10.1016/j.aprim.2018.05.014
dc.description.abstract
EVICT project has noted the increase in cannabis use in the Spanish youth population, and has studied its association with tobacco, concluding that: It has an influence in the learning to smoke process: The beginning can be combined and with bi-directional influence. It has an influence on dependence the development of dependence Their interaction is relevant in the development of dependence. It has an influence on toxicity: Smoking tobacco and cannabis generates greater problems than smoking tobacco alone. And, therefore, the EVICT team issues some considerations: Prevention considerations. Differentiate between therapeutic and recreational use. Smoking cannabis is not therapeutic nor innocuous, and can affect the development of nicotine dependence, or, less frequently, cannabis dependence. Approach and treatment considerations. In A first option of cessation of both must be proposed in people who consume tobacco and cannabis Harm Reduction. To those that only consume tobacco/cannabis: Harm Reduction programs should be more applicable to those in whom consumption is considered more problematic.
dc.format
application/pdf
dc.format
application/pdf
dc.language
spa
dc.publisher
Elsevier
dc.relation
Atención Primaria. 2020;52(1):47-53
dc.rights
© 2018 Los Autores. Publicado por Elsevier España, S.L.U. Este es un artículo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/)
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Tabaquisme
dc.subject
Cannabinoides -- Efectes fisiològics
dc.subject
Atención primaria
dc.subject
Cannabis
dc.subject
Primary care
dc.subject
Smoking
dc.subject
Tabaquismo
dc.title
¿Por qué y cómo tener en cuenta al cannabis en nuestros pacientes fumadores?
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)